OptiBiotix Health Plc (AIM: OPTI)
London
· Delayed Price · Currency is GBP · Price in GBX
18.12
+0.12 (0.67%)
Jan 22, 2025, 8:00 AM GMT+1
OptiBiotix Health Revenue
OptiBiotix Health had revenue of 276.00K GBP in the half year ending June 30, 2024, with 131.93% growth. This brings the company's revenue in the last twelve months to 569.00K, down -17.42% year-over-year. In the year 2023, OptiBiotix Health had annual revenue of 644.00K with 40.92% growth.
Revenue (ttm)
569.00K
Revenue Growth
-17.42%
P/S Ratio
29.51
Revenue / Employee
56.90K
Employees
10
Market Cap
17.63M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 644.00K | 187.00K | 40.92% |
Dec 31, 2022 | 457.00K | -1.76M | -79.35% |
Dec 31, 2021 | 2.21M | 689.75K | 45.28% |
Dec 31, 2020 | 1.52M | 835.66K | 121.54% |
Dec 31, 2019 | 687.58K | 173.30K | 33.70% |
Nov 30, 2018 | Pro | Pro | Pro |
Nov 30, 2017 | Pro | Pro | Pro |
Nov 30, 2016 | Pro | Pro | Pro |
Nov 30, 2015 | Pro | Pro | Pro |
Nov 30, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |